Jump to content

From journals and scientific sources

Primary sources for information and statistics.

325 topics in this forum

  1. Official guides to tapering off psychiatric medications

    By Altostrata,
    • 0 replies
    • 3,558 views

  2. Before you start a topic in Journals....

    By Altostrata,
    • 0 replies
    • 1,830 views

  3. Liver Enzymes Cytochrome P450 Drug Interaction Tables

    By Altostrata,
    • 6 replies
    • 7,620 views

  4. Papers about prolonged antidepressant withdrawal syndrome

    By Altostrata,
    • 30 replies
    • 10,908 views

  5. Important topics in Journals and Scientific Sources

    By Altostrata,
    • 3 replies
    • 3,083 views

  6. Primary sources for data, records, papers

    By Altostrata,
    • 11 replies
    • 3,057 views

  7. Guidance for Psychological Therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs

    By India,
    • 0 replies
    • 140 views

  8. Read, 2019, How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients

    By bubbles,
    • 4 replies
    • 561 views

  9. Henssler, 2019, Antidepressant Withdrawal and Rebound Phenomena

    By bubbles,
    • 1 reply
    • 300 views

  10. Shapiro, 2018, Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs

    By bubbles,
    • 0 replies
    • 167 views

  11. Eveleigh, 2019, Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators

    By bubbles,
    • 0 replies
    • 141 views

  12. Fluyau, 2018 Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation

    By Altostrata,
    • 0 replies
    • 170 views

  13. Stockmann, 2019 What it was like to stop an antidepressant

    By bubbles,
    • 5 replies
    • 438 views

  14. Hengartner, 2019,Antidepressant withdrawal – the tide is finally turning

    By Linus,
    • 1 reply
    • 361 views

  15. Munkholm Munkholm, 2019, Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

    By Linus,
    • 7 replies
    • 358 views

  16. Ruhe, 2019 Comment on Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Onmyway,   
    • 7 replies
    • 275 views

  17. Fava, 2017 The Potential Role of Iatrogenic Comorbidity in the Interaction between Pharmacotherapy and Psychotherapy in Anxiety Disorders

    By Shep,
    • 0 replies
    • 151 views

  18. Fava, 2019 Iatrogenic Factors in Psychopathology

    By Shep,
    • 0 replies
    • 188 views

  19. Baldessarini, 2019 Effects of Treatment Discontinuation in Clinical Psychopharmacology.

    By Itzakadoozee,
    • 5 replies
    • 478 views

  20. Khan, 2019 Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

    By Altostrata,
    • 0 replies
    • 505 views

  21. Moncrieff, 2005 Rethinking models of psychotropic drug action.

    By Altostrata,
    • 0 replies
    • 237 views

  22. Récalt, 2019 Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.

    By Altostrata,
    • 0 replies
    • 247 views

  23. Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Henosis,
    • 28 replies
    • 2,609 views

  24. Veltri, 2015 Medication-induced hypokalemia

    By Altostrata,
    • 0 replies
    • 140 views

  25. Aydemir, 2018 SSRI Induced Apathy Syndrome

    By Altostrata,
    • 6 replies
    • 704 views

  26. Oehrberg, 1995 Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

    By Altostrata,
    • 0 replies
    • 179 views

  27. Maund, 2019 Managing Antidepressant Discontinuation: A Systematic Review.

    By Altostrata,
    • 0 replies
    • 265 views

  28. Reisman, 2017 Sexual Consequences of Post-SSRI Syndrome.

    By Altostrata,   
    • 0 replies
    • 166 views

  29. Bala, 2018 Post-SSRI Sexual Dysfunction: A Literature Review.

    By Altostrata,   
    • 0 replies
    • 189 views

  30. Papp, 2018 Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

    By Altostrata,
    • 3 replies
    • 352 views

  31. Khan, 2014 Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d.

    By Altostrata,
    • 0 replies
    • 164 views

  32. Jha, 2018 When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.

    By Altostrata,
    • 0 replies
    • 306 views

  33. Frankel, 2018 An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.

    By Andie,   
    • 2 replies
    • 273 views

  34. Attfield, 2016 Preparation of Lower Dosages of SNRI Antidepressants to Ameliorate Discontinuation Symptoms: Two Case Studies

    By Andie,   
    • 1 reply
    • 223 views

  35. Kaufmann, 2009 Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?

    By Altostrata,
    • 0 replies
    • 240 views

  36. Fornaro, 2018 The Emergence of loss of efficacy during Antidepressant Drug Treatment for Major Depressive Disorder: An Integrative Review of Evidence, Mechanisms, and Clinical Implications.

    By Altostrata,   
    • 1 reply
    • 234 views
×
×
  • Create New...

Important Information

Terms of Use Privacy Policy

  I accept